Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Abstract Text:

Josep Maria Haro,Saena Arbabzadeh-Bouchez,Traolach S Brugha,Giovanni de Girolamo,Margaret E Guyer,Robert Jin,Jean Pierre Lepine,Fausto Mazzi,Blanca Reneses,Gemma Vilagut,Nancy A Sampson,Ronald C Kessler,

The DSM-IV diagnoses generated by the fully structured lay-administered Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) in the WHO World Mental Health (WMH) surveys were compared to diagnoses based on follow-up interviews with the clinician-administered non-patient edition of the Structured Clinical Interview for DSM-IV (SCID) in probability subsamples of the WMH surveys in France, Italy, Spain, and the US. CIDI cases were oversampled. The clinical reappraisal samples were weighted to adjust for this oversampling. Separate samples were assessed for lifetime and 12-month prevalence. Moderate to good individual-level CIDI-SCID concordance was found for lifetime prevalence estimates of most disorders. The area under the ROC curve (AUC, a measure of classification accuracy that is not influenced by disorder prevalence) was 0.76 for the dichotomous classification of having any of the lifetime DSM-IV anxiety, mood and substance disorders assessed in the surveys and in the range 0.62-0.93 for individual disorders, with an inter-quartile range (IQR) of 0.71-0.86. Concordance increased when CIDI symptom-level data were added to predict SCID diagnoses in logistic regression equations. AUC for individual disorders in these equations was in the range 0.74-0.99, with an IQR of 0.87-0.96. CIDI lifetime prevalence estimates were generally conservative relative to SCID estimates. CIDI-SCID concordance for 12-month prevalence estimates could be studied powerfully only for two disorder classes, any anxiety disorder (AUC = 0.88) and any mood disorder (AUC = 0.83). As with lifetime prevalence, 12-month concordance improved when CIDI symptom-level data were added to predict SCID diagnoses. CIDI 12-month prevalence estimates were unbiased relative to SCID estimates. The validity of the CIDI is likely to be under-estimated in these comparisons due to the fact that the reliability of the SCID diagnoses, which is presumably less than perfect, sets a ceiling on maximum CIDI-SCID concordance.

Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Publishing Authors By Initials

JM Haro,S Arbabzadeh-Bouchez,TS Brugha,G de Girolamo,ME Guyer,R Jin,JP Lepine,F Mazzi,B Reneses,G Vilagut,NA Sampson,RC Kessler,

For similar health care economics and organizations: organizations: international agencies: united nations: world health organization research abstracts see: health care economics and organizations: organizations: international agencies: united nations: world health organization research

PUBMED ID PMID:

MEDLINE DATE:

Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: International journal of methods in psychiatric re

VOLUME: 15

Page Numbers: 167-80

Journal Abbreviation:

ISSN: 1049-8931

DAY: 3

MONTH: Dec

YEAR: 2006

Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9111433

Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Keywords Mesh Terms:

KEYWORDS: World Health Organization

MESH TERMS: standards

Chemical & Substance for Abstract: Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

AFFILIATION:

Country: England

AGENCY: United States NIMH

GRANT: U01-MH60220

ACRONYM: MH

MEDLINETA: Int J Methods Psychiatr Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Concordance of the Composite International Diagnostic Interview Version 30 CIDI 30 with standardized clinical assessments in the WHO World Mental Health surveys Related Publications

• About the suboccipital part of the vertebral artery and the neighboring bone-joint and nerve relationships.
• Arthritis and physical-mental comorbidity in metropolitan China.
• Broadening the definition of generalized anxiety disorder: effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication.
• Changes in surgical therapy for Crohn's disease over 33 years: a prospective longitudinal study.
• Clinical differences among patients treated for mental health problems in general medical and specialty mental health settings in the National Comorbidity Survey Replication.
• Complete robotic-assistance during laparoscopic living donor nephrectomies: an evaluation of 38 procedures at a single site.
• Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.
• DSM-IV personality disorders in the National Comorbidity Survey Replication.
• Delay in initial treatment contact after first onset of mental disorders in metropolitan China.
• Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate.
• Developmental changes in progenitor cell responsiveness to cytokines.
• Dual function of Sox1 in telencephalic progenitor cells.
• FoxD3 and Grg4 physically interact to repress transcription and induce mesoderm in Xenopus.
• FoxD3 regulation of Nodal in the Spemann organizer is essential for Xenopus dorsal mesoderm development.
• Lifetime prevalence and inter-cohort variation in DSM-IV disorders in metropolitan China.
• Lifetime prevalence, correlates, and persistence of oppositional defiant disorder: results from the National Comorbidity Survey Replication.
• Mental disorders among English-speaking Mexican immigrants to the US compared to a national sample of Mexicans.
• Mental health service use among hurricane Katrina survivors in the eight months after the disaster.
• Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
• Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior.
• Postcircumcision necrosis of the glans penis: gray-scale and color Doppler sonographic findings.
• Prevalence of the EH1 Groucho interaction motif in the metazoan Fox family of transcriptional regulators.
• Psychiatric epidemiology: challenges and opportunities.
• Risk for psychiatric disorder among immigrants and their US-born descendants: evidence from the National Comorbidity Survey Replication.
• Sonic hedgehog and BMP2 exert opposing actions on proliferation and differentiation of embryonic neural progenitor cells.
• Telephone screening, outreach, and care management for depressed workers and impact on clinical and work productivity outcomes: a randomized controlled trial.
• The costs and benefits of enhanced depression care to employers.
• The impact of comorbidity of mental and physical conditions on role disability in the US adult household population.
• The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.
• Understanding mental health treatment in persons without mental diagnoses: results from the National Comorbidity Survey Replication.